Literature DB >> 20179167

Identification and validation of lupus nephritis cases using administrative data.

L B Chibnik1, E M Massarotti, K H Costenbader.   

Abstract

Large administrative databases such as Medicaid billing databases could be used to study care and outcomes of lupus nephritis if these patients could be correctly identified from claims data. We aimed to develop and validate an algorithm for the correct identification of cases of lupus nephritis using ICD-9 billing codes. We used the Research Patient Data Resource query tool at our institution to identify patients with potential lupus nephritis. We compared four ICD-9 code based strategies, identifying patients seen between 2000 and 2007 with Medicaid medical insurance with greater than two claims for a diagnosis of SLE (ICD-9 code 710.0) and a combination of greater than two nephrologist visits and/or renal ICD-9 codes. We assessed performance using the positive predictive value. Two hundred and thirty four subjects were identified and medical records reviewed. Our third strategy, based on a combination of lupus and renal ICD-9 codes and nephrologist encounter claims, had the highest positive predictive value (88%) for the identification of patients with lupus nephritis. This strategy may offer a sound method of identifying patients with lupus nephritis for health services research in addition to serving as a model for using claims data as a way to better understand rare diseases such as lupus.

Entities:  

Mesh:

Year:  2010        PMID: 20179167      PMCID: PMC2964351          DOI: 10.1177/0961203309356289

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  18 in total

1.  Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.

Authors:  C Gabay; N Cakir; F Moral; P Roux-Lombard; O Meyer; J M Dayer; T Vischer; H Yazici; P A Guerne
Journal:  J Rheumatol       Date:  1997-02       Impact factor: 4.666

2.  An epidemiologic analysis of end-stage lupus nephritis.

Authors:  K Iseki; F Miyasato; T Oura; H Uehara; K Nishime; K Fukiyama
Journal:  Am J Kidney Dis       Date:  1994-04       Impact factor: 8.860

3.  Access to renal transplantation among patients with end-stage renal disease due to lupus nephritis.

Authors:  M M Ward
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

4.  Hypertension increases the risk of renal deterioration in systemic lupus erythematosus.

Authors:  E M Ginzler; D T Felson; J M Anthony; J J Anderson
Journal:  J Rheumatol       Date:  1993-10       Impact factor: 4.666

Review 5.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  SLE patients with renal damage incur higher health care costs.

Authors:  A E Clarke; P Panopalis; M Petri; S Manzi; D A Isenberg; C Gordon; J-L Senécal; L Joseph; Y St Pierre; T Li
Journal:  Rheumatology (Oxford)       Date:  2008-01-30       Impact factor: 7.580

8.  Validation of diagnostic codes within medical services claims.

Authors:  Machelle Wilchesky; Robyn M Tamblyn; Allen Huang
Journal:  J Clin Epidemiol       Date:  2004-02       Impact factor: 6.437

9.  Prognostic determinants in lupus nephritis: a long-term clinicopathologic study.

Authors:  J V Donadio; G M Hart; E J Bergstralh; K E Holley
Journal:  Lupus       Date:  1995-04       Impact factor: 2.911

10.  Patterns of renal injury in systemic lupus erythematosus: light and immunofluorescence microscopic observations.

Authors:  E Grishman; M A Gerber; J Churg
Journal:  Am J Kidney Dis       Date:  1982-07       Impact factor: 8.860

View more
  45 in total

1.  Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US Medicaid Systemic Lupus Erythematosus Population, 2000-2010.

Authors:  Tzu-Chieh Lin; Michael F Marmor; Medha Barbhaiya; Hongshu Guan; Sarah K Chen; Candace H Feldman; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11       Impact factor: 4.794

2.  Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States.

Authors:  Jinoos Yazdany; Candace H Feldman; Jun Liu; Michael M Ward; Michael A Fischer; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

3.  Comparative Fracture Risks Among United States Medicaid Enrollees With and Those Without Systemic Lupus Erythematosus.

Authors:  Sara K Tedeschi; Seoyoung C Kim; Hongshu Guan; Jennifer M Grossman; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2019-06-05       Impact factor: 10.995

4.  Probabilistic techniques for obtaining accurate patient counts in Clinical Data Warehouses.

Authors:  Risa B Myers; Jorge R Herskovic
Journal:  J Biomed Inform       Date:  2011-10-01       Impact factor: 6.317

5.  Disease Outcomes and Care Fragmentation Among Patients With Systemic Lupus Erythematosus.

Authors:  Theresa L Walunas; Kathryn L Jackson; Anh H Chung; Karen A Mancera-Cuevas; Daniel L Erickson; Rosalind Ramsey-Goldman; Abel Kho
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08-08       Impact factor: 4.794

6.  Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure.

Authors:  Sameer Prasada; Adovich Rivera; Arvind Nishtala; Anna E Pawlowski; Arjun Sinha; Joshua D Bundy; Simran A Chadha; Faraz S Ahmad; Sadiya S Khan; Chad Achenbach; Frank J Palella; Rosalind Ramsey-Goldman; Yvonne C Lee; Jonathan I Silverberg; Babafemi O Taiwo; Sanjiv J Shah; Donald M Lloyd-Jones; Matthew J Feinstein
Journal:  JACC Heart Fail       Date:  2020-04-08       Impact factor: 12.035

7.  Chest pain in lupus patients: the emergency department experience.

Authors:  Masoom Modi; Mariko L Ishimori; Vaneet K Sandhu; Daniel J Wallace; Michael H Weisman
Journal:  Clin Rheumatol       Date:  2015-04-26       Impact factor: 2.980

8.  Identifying Patients with Rare Disease Using Electronic Health Record Data: The Kaiser Permanente Southern California Membranous Nephropathy Cohort.

Authors:  Amy Z Sun; Yu-Hsiang Shu; Teresa N Harrison; Aviv Hever; Steven J Jacobsen; Michelle M O'Shaughnessy; John J Sim
Journal:  Perm J       Date:  2020-02-07

9.  Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.

Authors:  Candace H Feldman; Jamie Collins; Zhi Zhang; Chang Xu; S V Subramanian; Ichiro Kawachi; Daniel H Solomon; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11       Impact factor: 4.794

10.  Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.

Authors:  Linda T Hiraki; Candace H Feldman; Jun Liu; Graciela S Alarcón; Michael A Fischer; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.